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Summary
Background and aims: Salmonella infections remain a major public health problem in
developing countries. The occurrence of infections caused by antimicrobial-resistant
Salmonella has been on the rise complicating the available therapeutic options. The
study aimed to determine the antibiograms and genotypes of prevalent Salmonella
serotypes.
Methods: A retrospective study involving 80 stool and extra-intestinal Salmonella
strains collected over a 18-month period (January 2005—June 2006) from a tertiary
hospital in Penang, Malaysia was conducted. Isolates were examined for resistance
to 14 antimicrobial drugs and the clonality of the strains was determined by PFGE.
Results: Twenty-one serotypes were identiﬁed, themost common being S. enteritidis
(42.5%) followed by S. corvallis (11.25%) and S. braenderup (11.25%). S. enteritidis
was signiﬁcantly more common amongst the extra-intestinal isolates compared to
stool isolates (74.2% versus 22.4%, p < 0.0001). Overall, the highest resistance was
observed for tetracycline (66.3%), sulphonamides (56.3%), streptomycin (32.5%),
trimethoprim (28.8%) and nalidixic acid (27.5%). Amongst the 31 invasive extra-
intestinal isolates, resistance towards therapeutically relevant antibiotics was as
follows: co-trimoxazole (38.7%), ampicillin (29%) and ceftriaxone (3.2%). Although
there was no detectable resistance towards chloramphenicol and ciproﬂoxacin, 29%
strains showed nalidixic acid resistance. About 41% of the 80 isolates were multidrug-
resistant. PFGE subtyped the 78 Salmonella isolates to 33 distinct XbaI-pulsotypes.
Isolates within the serotypes S. enteritidis, S. corvallis, S. branderup and S. fasta
were more homogeneous while S. typhi and S. weltervden were genetically more
diverse.
∗ Corresponding author. Tel.: +60 3 79674437; fax: +60 3 79675908.
E-mail address: thongkl@um.edu.my (K.L. Thong).
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Conclusions: The high percentage of multidrug-resistant Salmonella strains is worrying
and is of public health concern. PFGE was a useful and discriminative method for
assessing the genetic diversity of Salmonellae.
dulaziz University for Health Sciences. Published by Elsevier
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30g; sulphonamide 300g; trimetho-
prim/sulphamethoxazole (co-trimoxazole) 25g;© 2011 King Saud Bin Ab
Ltd. All rights reserved.
Introduction
The occurrence of food-borne diseases caused
by non-typhoid Salmonella (NTS) is an important
public health problem worldwide. Although self-
limiting acute gastroenteritis is the most common
clinical manifestation, invasion beyond the gas-
trointestinal tract occurs in approximately 5% of
the patients with NTS gastroenteritis resulting in
bacteraemia [1]. As a larger proportion of patients
have become immunocompromised either due to
certain primary diseases or modern aggressive ther-
apies, the occurrence of NTS invasive disease
appears to be increasing [2]. Invasive diseases asso-
ciated with NTS infections include bacteraemia,
mycotic aneurysm, pleuropulmonary infections,
osteomyelitis, visceral abscess and septic arthri-
tis [3]. Although antimicrobials are not generally
recommended for the treatment of uncomplicated
Salmonella gastroenteritis, therapy may be crucial
in immunocompromised patients or in those with
extra-intestinal infections.
The incidence of human infections caused by
antimicrobial-resistant Salmonella has been on the
rise and is threatening to become a serious pub-
lic health crisis [4,5]. During the past two decades,
multiple resistances to conventional antimicro-
bial agents such as ampicillin, chlorampheni-
col and trimethoprim/sulphamethoxazole have
been reported from many countries [4,5] Third-
generation cephalosporins and ﬂuoroquinolones are
recommended as alternatives in such settings.
Of greater concern is the growing resistance of
Salmonella to extended-spectrum cephalosporins
[6] and ﬂuoroquinolones [4,7] which are likely to
lead to therapeutic problems.
Subtyping of Salmonella serotypes is important
for epidemiological investigations of Salmonella
outbreaks and surveillance purposes. Although con-
ventional phenotypic methods such as biotyping,
serotyping and phage typing have been widely used,
they are less discriminative. In contrast, molecular
approaches such as pulsed-ﬁeld gel electrophoresis
(PFGE) offer higher discrimination, typeability and
t
1
neproducibility [8]. PFGE has been widely regarded
s the ‘‘gold standard’’ for Salmonella subtyping
ecause of its high discriminatory ability and the
vailability of standardized protocols [9].
This study was undertaken to determine the
ntibiotic resistance patterns, serotype distribution
nd the pulsotypes amongst the Salmonella iso-
ates from a tertiary hospital in Penang, Malaysia.
his is the ﬁrst report of the diversity of clinical
almonella from this tertiary hospital.
aterials and methods
total of 80 stool and extra-intestinal Salmonella
trains that had been collected over an 18 month
eriod (January 2005—June 2006) were examined
or antimicrobial resistance to 13 antimicrobial
rugs. The strains were obtained from the micro-
iology laboratory of an 1100-bedded Malaysian
ertiary hospital which serves as a referral hospital
or many disciplines including haematology, oncol-
gy, rheumatology, infectious diseases, nephrology,
ardiology, cardiothoracic surgery as well as serv-
ng the local population. Only one isolate per person
as included for analysis purpose.
dentiﬁcation and antibiotic susceptibility
ll isolates were identiﬁed as Salmonella accord-
ng to standard microbiological techniques [10].
erotyping of all Salmonella isolates was performed
ccording to Kaufmann—White scheme using O and
antisera (Difco, BD BBL) [11]. Antibiotic suscep-
ibility was performed using a panel of 14 different
ntimicrobial agents and was determined by means
f Kirby —Bauer disk diffusion method using the
uidelines provided by Clinical Laboratory Standard
nstitute (CLSI) [12]. The Salmonella isolates were
ested against ampicillin 10g; chloramphenicolrimethoprim 5g; tetracycline 30g; gentamicin
0g; kanamycin 30g; streptomycin 10g;
alidixic acid 30g; ciproﬂoxacin 5g; ceftriaxone
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Lntibiotic susceptibility and PFGE of clinical Salmo
0g; cephalexin 30g; cefotaxime 30g.
scherichia coli ATCC 25,922 was used as a refer-
nce strain. Antimicrobial agents were categorized
ccording to CLSI antimicrobial subclasses and
solates were assigned to categories depending on
he number of antibiotic subclass it was resistant
o. Multidrug-resistance was deﬁned as resistance
o three or more antimicrobials subclasses.
Data was analyzed using the Statistical Package
or Social Sciences (SPSS version 15.0). Compari-
on amongst certain variables was determined by
he Fisher’s exact test or Chi-squared test. The p-
alue < 0.05 (two-tailed) was taken as the level of
igniﬁcance.
ulsed-ﬁeld gel electrophoresis typing
enomic DNA was prepared and embedded in
garose plugs as described previously [8]. Brieﬂy,
qual volumes of 1% Seakem Gold agarose (Cam-
rex Bio Science Rockland, Inc., Rockland, ME,
SA) were mixed with 100L cell standardized
uspension (turbidity = 0.5) to form plugs. The
acteria were lysed within the plugs with cell
ysis buffer (50mM Tris; 50mM ethylenediaminete-
raacetic acid [TE buffer; pH 8.0], 1% sarcosine,
mg/mL proteinase K) and incubated at 54 ◦C for
h. The plugs were then washed thoroughly with
terile deionised water (twice) and TE buffer. Then,
.5-mm plug slices were digested with 10 units
f restriction enzyme XbaI (Promega) at 37 ◦C.
he plug slices were then loaded onto a 1.0%
garose gel (Sigma Type 1; Sigma Corp., St. Louis,
O, USA). PFGE was performed with the CHEF
R II (BioRad, Hercules, CA, USA) with the fol-
owing conditions: 200 V for 26 h with pulse times
f 2.2—63.8 s at 14 ◦C. Gels were photographed
nder ultraviolet light after staining with ethidium
romide (0.5g/mL). XbaI restricted-Salmonella
raenderup, strain H9812 was used as the DNA size
arker and control.
ingerprint pattern analysis
he banding patterns generated by PFGE were
nalyzed with GelCompar II, (Applied Maths, Kor-
rijk, Belgium). All the PFGE proﬁles were assigned
rbitrary designation and analyzed by deﬁning a
imilarity (Dice) coefﬁcient F = 2nxy/(nx + ny) where
x = number of fragments for isolate X, ny = number
f fragments for isolate Y, and nxy = number of
hared fragments between isolates X and Y [8].
luster analysis of the pulsotypes was carried out
ased on the unweighted pair group method with
rithmetic averages (UPGMA) using the position tol-
rance at 1%.
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esults
erotypes
n the present study, 80 Salmonella isolates were
ecovered from different sites (one isolate per
atient). Overall, S. enteritidis was the predom-
nant serotype accounting for 42.5% of isolates,
ollowed by S. corvallis (11.3%) and S. braenderup
11.3%). The other serotypes isolated were S. farsta
nd S. typhi (6.3% each), S. weltevreden (3.8%), S.
agos and S. tshiongwe (2.5% each), and 1 isolate
ach (1.3%) for S. albany, S. biafra, S. eppendorf, S.
ato, S. limete, S. rissen, S. sandiego, S. paratyphi
and S. typhimurium. S. enteritidis was signiﬁ-
antly more common amongst the extra-intestinal
23/31) isolates compared to stool (11/49) isolates
74.2% versus 22.4%, p < 0.0001).
ntibiotic susceptibility
verall, only 12.5% (10/80) of isolates demon-
trated no resistance to any antimicrobials. The
requency of resistance to individual antimicrobials
s shown in Table 1. Overall, tetracycline was associ-
ted with highest resistance rates (66.3%) followed
y sulphonamides (56.3%), streptomycin (32.5%)
nd trimethoprim (28.8%). Against therapeutically
elevant ﬁrst-line antimicrobials, resistance was
ighest against co-trimoxazole (25%) followed by
mpicillin (18.8%) and chloramphenicol (5%). Of
articular note was a high proportion of isolates
hat were resistance to nalidixic acid (27.5%).
mongst the 22 nalidixic acid-resistant isolates,
hree had concurrent ciproﬂoxacin resistance and
hree isolates showed intermediate susceptibility
owards ciproﬂoxacin. Five isolates (6.3%) showed
esistance towards ceftriaxone. Resistance to cef-
riaxone was identiﬁed in three stool- and two urine
solates and was associated with 3 isolates of S.
nteritidis and one isolate each for S. lagos and
. eppendorf.
Amongst the 31 invasive extra-intestinal iso-
ates, resistance towards therapeutically relevant
ntibiotics was as follows: co-trimoxazole (38.7%),
mpicillin (29%) and ceftriaxone (3.2%). Although
here was no detectable resistance towards
iproﬂoxacin amongst the extra-intestinal iso-
ates, almost one-third (29%) of these isolates
emonstrated resistance towards nalidixic acid.
ikewise, no resistance towards chloramphenicol
as observed. When comparing the resistance rates
etween extra-intestinal and stool isolates, extra-
ntestinal isolates were found to have signiﬁcantly
igher rates of resistance towards sulphonamides
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Table 1 Antimicrobial susceptibility of 80 Salmonella isolates from a local tertiary hospital, Malaysia.
Antimicrobial Sensitive Intermediate Resistant
N (%) N (%) N (%)
Ampicillin 60(75) 5(6.3) 15(18.8)
Chloramphenicol 73(91.3) 2(2.5) 4(5)
Gentamicin 71(88.8) 4(5) 5(6.3)
Kanamycin 63(78.8) 6(7.5) 11(13.8)
Streptomycin 36(45) 18(22.5) 26(32.5)
Nalidixic acid 48(60) 10(12.5) 22(27.5)
Ciproﬂoxacin 74(92.5) 3(3.8) 3(3.8)
Sulphonamide 30(37.5) 5(6.3) 45(56.3)
Trimethoprim 56(70) 1(1.3) 23(28.8)
Trimethoprim-sulphamethoxazole 58(72.5) 2(2.5) 20(25)
Tetracycline 26(32.5) 1(1.3) 53(66.3)
Cephalexin 62(77.5) 1(1.3) 17(21.3)
Ceftriaxone 75(93.8) 1(1.3) 5(6.25)
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(74.2% versus 44.9%; p = 0.01), trimethoprim (45.2%
versus 18.4%; p = 0.01) and co-trimoxazole (38.7%
versus 16.3%; p = 0.024), while stool isolates had
higher rates of resistance towards cephalexin
(28.6% versus 9.7%; p = 0.044) and streptomycin
(40.8% versus 19.4%; p = 0.046).
Overall 13.8% (11/80) of Salmonella isolates
were resistant to one class of antimicrobials and
41.3% (33/80) were multidrug-resistant, deﬁned
as resistance to three or more antimicrobials
classes (Table 2). Multidrug-resistance was signiﬁ-
cantly less common amongst S. enteritidis (9/34)
compared to other Salmonella serotypes (24/46)
(26.4% versus 52.2%, p = 0.021). There was no
statistical difference between the proportion of
multidrug-resistance isolates from extra-intestinal
sites compared with stool isolates (41.9% versus
40.8%, p = 0.92).
Genetic diversity of Salmonella by PFGE
DNA ﬁngerprinting of 78 Salmonella isolates by
PFGE revealed 33 distinct XbaI restriction pat-
terns referred to as pulsotypes (Dice coefﬁcient,
F = 0.50—1.00). All the pulsotypes were repro-
ducible when the PFGE analysis was repeated once.
PFGE was very discriminative as it distinctly sepa-
rated all isolates of different Salmonella serotypes.
A cluster analysis of the pulsotypes is depicted in
the dendrogram (Fig. 1). At 80% similarity, ﬁve clus-
ters were obtained. Each cluster is comprised of
members of the same Salmonella serotypes. Within
the S. enteritidis cluster, the 34 isolates were dif-
ferentiated into 7 different pulsotypes (<4 bands
difference), with the majority belonging to pul-
stotype SEXba1 (n = 20). Pulstoypes SEXba2 (n = 5)
r
ﬁ
t
l6(7.5) 4(5)
nd SEXba3 (n = 5) differed from SEXba1 by 2 bands
Table 3). In the Corvallis cluster, the 9 isolates were
ubtyped into 2 pulsotypes (<2 bands difference)
ith 7 of them being indistinguishable (Table 3). All
he 9 S. braenderup isolates were indistinguishable.
. farsta (n = 5) and S. typhi (n = 5) were sub-
yped into 4 and 5 pulsotypes, respectively. Other
inor serotypes had unique pulstotypes (Table 3
nd Fig. 1). Overall, the genetic diversity isolates
ithin the serotypes S. enteritidis, S. corvallis, S.
randerup and S. fasta was low while members of
. typhi and S. weltervden were genetically more
iverse.
iscussion
almonellae are important food- and water-borne
athogens associated with gastroenteritis, bac-
eraemia and focal infections in humans and
re especially problematic in immunocompromised
atients [2]. Thus, the increasing reports of resis-
ance to multiple antimicrobial agents are a cause
f concern as it can lead to therapeutic fail-
re. The growing antimicrobial resistance amongst
uman Salmonella isolates has been linked to the
isuse and overuse of antimicrobials in the breed-
ng and agricultural sector, acquired by ingestion
f foods contaminated with antimicrobial-resistant
almonella [13]. Multidrug-resistance, deﬁned as
esistance to three or more classes of antibi-
tics was observed in 41.3% of our isolates. The
esistance rates towards therapeutically relevant
rst-line antibiotics, although relatively high (co-
rimoxazole, 25% and ampicillin, 18.8%), was still
ower compared to reports from countries like
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Figure 1 Dendrogram generated using the Dice coefﬁcient based on PFGE proﬁles of the 80 Salmonella isolates
restricted with XbaI, constructed using UPGMA algorithm (GelComparII).
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Table 2 Antimicrobial resistance of Salmonella isolates according to subclasses.
Total N = 80 Extraintestinal N = 31 Stool N = 49
None 10(12.5%) 4(12.9%) 6(12.2%)
One CLSI subclassa 11(13.8%) 3(9.7%) 8(16.3%)
Two CLSI subclasses 26(32.5%) 11(35.5%) 15(30.6%)
Three CLSI subclasses 16(20%) 7(22.6%) 9(18.4%)
Four CLSI subclasses 8(10%) 3(9.7%) 5(10.2%)
Five CLSI subclasses 6(7.5%) 3(9.7) 3(6.1%)
Six CLSI subclasses 1(1.3%) 0 1(2.0%)
Seven CLSI subclasses 2(2.5%) 0 2(4.1%)
At least ACSSuTb 2(2.5%) 0 2(4.1%)
At least ACSuTmc 2(2.5%) 0 2(4.1%)
Quinoloned 22(27.5%) 9(29%) 13(26.5%)
3rd GC 5(6.3%) 2(6.5%) 3(6.1%)
a CLSI, Clinical and Laboratory Standards Institute. Subclasses included: penicillins (ampicillin); aminoglycosides (kanamycin,
gentamicin, streptomycin); ﬁrst-generation cephalosporins (cephalexin); third-generation cephalosporins (ceftriaxone); folate
pathway inhibitors (trimethoprim-sulphamethoxazole, sulphonamides, trimethoprim); phenicols (chloramphenicol); quinolones
(nalidixic acid, ciproﬂoxacin); tetracyclines (tetracycline).
b ACSSuT, ampicillin, chloramphenicol, streptomycin, sulphamethoxazole/sulphisoxazole, tetracycline.
amet
cc ACSuTm, ampicillin, chloramphenicol, trimethoprim-sulph
d Resistant to ciproﬂoxacin and/or nalidixic acid.
Taiwan and Thailand [3,14]. Interestingly, only 5%
of the Salmonella strains in our study were resis-
tant to chloramphenicol, compared to much higher
rates noted in other Asian countries like Taiwan,
Thailand and Korea [14].
r
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Table 3 Distribution of pulsotypes of clinical Salmonella is
Salmonella serotypes Pul
S. enteritidis SEX
SEX
SEX
SEX
SEX
SEX
SEX
S. braenderup SBD
S. corvallis SCV
SCV
S. typhi STX
STX
STX
STX
STX
S. lagos SLX
SLX
S. farsta SFX
SFX
SFX
S. welterveden SWX
SWX
SWX
Each of the following serotypes represented by one strain each with
S. albany; S. paratyphi; S. biafra; S. hato; S. rissen; S. limete; Salmhoxazole.
Ciproﬂoxacin and third-generation
ephalosporins are the antimicrobial agents
ecommended for the treatment of complicated
xtra-intestinal infections. Continued emergence
nd dissemination of Salmonella strains with
olates.
sotypes (no/source)
ba1 (n = 20) (blood = 10, stools = 7, urine = 2, ﬂuid n = 1)
ba2 (n = 5) (blood = 4, stools n = 1)
ba3 (n = 5) (blood = 1, stools = 3, ﬂuid n = 1)
ba4 (n = 1, blood)
ba5 (n = 1, blood)
ba6 (n = 1, urine)
ba7 (n = 1, blood)
Xba1 (n = 9, stools)
Xba1 (n = 7, stools)
Xba2 (n = 2, stools)
ba1 (n = 1, blood)
ba2 (n = 1, blood)
ba3 (n = 1, blood)
ba4 (n = 1, blood)
ba5 (n = 1, stool)
ba1 (n = 1, stools)
ba2 (n = 1, stools)
ba1 (n = 3, stools)
ba2 (n = 1, stools)
ba3 (n = 1, stools)
ba1 (n = 1, stools)
ba2 (n = 1, stools)
ba3 (n = 1, stools)
unique pulsotype: S. typhimurium; S. eppendorf; S. sandiego;
onella spp (n = 2).
A nella
r
a
[
(
c
i
e
[
c
v
[
r
E
u
t
I
i
a
c
o
n
t
i
S
i
c
I
s
c
t
g
s
c
s
(
f
s
t
t
f
t
i
i
i
c
m
i
S
S
p
i
m
w
s
o
a
o
[
i
g
s
a
S
o
S
p
s
t
d
e
L
l
M
m
p
c
d
2
C
I
p
w
i
u
g
t
t
M
A
F
v
f
D
d
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educed susceptibility to these antimicrobials
re likely to have worrying clinical consequences
4—7]. Extended spectrum beta-lactamases
ESBLs) that confer resistance to third-generation
ephalosporins are increasingly being reported
n the Enterobacteriaceae and concern has been
xpressed regarding their presence in Salmonella
6]. The rate of resistance to ceftriaxone and
iproﬂoxacin found in the present study, although
ery low compared to some countries is Asia
3,6,7,14], is still a cause for great concern as
esistant enteric organisms disseminates quickly.
xcept for one strain which was isolated from
rine, all the ciproﬂoxacin and ceftriaxone resis-
ant strains were recovered from stool samples.
n the present study, a high percentage of the
solates were noted to be resistant to nalidixic
cid, (overall 27.5% and extra-intestinal 29%)
ompared to an overall ciproﬂoxacin resistance of
nly 3.8%. Although the MICs of ciproﬂoxacin were
ot tested, studies have shown that the risk of
reatment failure is increased when ciproﬂoxacin
s used to treat patients with infection due to
almonella species resistant to nalidixic acid, even
f the organism is considered to be susceptible to
iproﬂoxacin according to current standards [15].
n the present study, multidrug-resistance was
igniﬁcantly less common amongst S. enteritidis
ompared with other serotypes, concurring with
he ﬁndings from other studies [16].
There has been a concern involving the emer-
ence and dissemination of multidrug resistant
trains such as S. typhimurium phage type DT104,
onferring resistance to ampicillin, streptomycin,
ulphonamide, chloramphenicol and tetracycline
resistance-type ASSuCT); which could be trans-
erred clonally and also horizontally to other
erotypes [17]. Although the only isolate of S.
yphimurium in the present study did not exhibit
he ASSuCT R-type resistance, two other isolates
rom stool (S. albany and S. limete) did show this
ype of resistance.
S. enteritidis was the most frequent serotype
n our locality, both from stool as well as extra-
ntestinal isolates, a trend similar to that reported
n countries like Japan, Korea and Thailand [18]. S.
holeraesuis and S. typhimurium, which are com-
on in Taiwan [14], represented only 1.3% of our
solates. Less common serotypes, such as S. rissen,
. biafra, S. sandiego, S. eppendorf, S. hata, and
. limete were observed only once during the study
eriod and this indicates a diversity of clinically
mportant Salmonella.
The prevalence of different serotypes and their
ostly dissimilar DNA ﬁngerprint proﬁles correlate
ith the fact that the isolates were derived fromisolates 71
poradic cases of gastroenteritis sampled through-
ut the study period. Multiple pulsotypes are often
ssociated with sporadic cases in endemic areas as
pposed to single PFGE genotypes in outbreak cases
19]. The indistinguishable S. branderup could have
mplied that the isolates were probably from a sin-
le episode of gastroenteritis as stool samples were
ent to laboratory on the same the day and had
lmost identical antibiograms. Similarly, 3 out of 5
. farsta were indistinguishable by PFGE and antibi-
grams. The lack of genetic diversity observed for
. enteritidis as determined by PFGE is not sur-
rising as previous studies have shown that this
erotype is highly clonal [20]. The SEXbaI pat-
ern seen in this study was also observed as the
ominant pattern generated by XbaI-restricted S.
nteritidis isolates in a 1995 outbreak in Kuala
umpur [20]. This suggests that S. enteritidis iso-
ates with this particular proﬁle are endemic in
alaysia and have been genetically quite stable for
ore than a decade. On the other hand, the XbaI-
roﬁles of S. weltevreden isolates in this study were
ompletely different from the clinical isolates from
ifferent parts of Malaysia isolated from 1996 to
001 [8].
onclusion
n conclusion, this study highlights a widespread
resence of multidrug-resistant Salmonella strains
hich is of public health concern and has important
mplications on therapeutic management. PFGE is a
seful and discriminative method for assessing the
enetic diversity of Salmonellae. It is hoped that
he data reported herein will contribute towards
he epidemiological monitoring of Salmonella in
alaysia.
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